European shares climb on vaccine hopes, mixed earnings


For a live blog on European stocks, type LIVE/ in an Eikon news window

July 15 (Reuters) - European shares rebounded on Wednesday from losses in the previous session, bolstered by positive updates on a potential COVID-19 vaccine, while investors weighed a mixed bag of quarterly reports at the start of earnings season.

The pan-European STOXX 600 .STOXX rose 0.8% by 0720 GMT, with travel & leisure .SXTP and miners .SXPP leading gains.

Market sentiment got a boost after U.S. biotech firm Moderna Inc's MRNA.O experimental vaccine for COVID-19 showed it was safe and provoked immune responses in an ongoing early-stage study.

Hopes were high among investors heading into a EU summit later this week that leaders will agree on a recovery fund of 750 billion euros for pandemic-hammered economies.

Swedish telecom operator Tele2 AB TEL2b.ST jumped 4.1% as it reaffirmed its 2020 earnings outlook and plans for an extra shareholder payout.

Semiconductor equipment maker ASML Holding NV ASML.AS slipped 1.3% despite forecasting overall growth for 2020.

British fashion brand Burberry BRBY.L dropped 5.1% as it warned second-quarter revenue will remain impacted by the pandemic.

(Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak Dasgupta)

((; within U.S. +1 646 223 8780; outside U.S. +91 80 6182 2787;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.